We are the global biologics research and development arm of our parent company AstraZeneca, a recognized global leader in biopharmaceutical research and development. By combining AstraZeneca’s worldwide presence with our distinct and unique culture, processes, and standards, we continue to solve global healthcare challenges, redefine science, deliver better medicines, and help people live longer, healthier lives.

Research Grants 242 show all


$23.2M
2015

$16.6M
2016

$41.3M
2017

$13M
2018

$26.3M
2019

Patents 4,959show all

  • 1,849
    C07K - Peptides
  • 1,798
    A61K - Preparations for medical, dental, or toilet purposes
  • 686
    C12N - Microorganisms or enzymes
  • 261
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 189
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 121
    Y02A - Technologies for adaptation to climate change
  • 105
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 82
    C07D - Heterocyclic compounds
  • 42
    C40B - Combinatorial chemistry
  • 35
    C12Y - Enzymes

Clinical Trials 583show all

200Phase 2131Phase 1102N/A52Phase 1/Phase 240Phase 331Other

SEC Filings show all


136
8-K

33
10-Q

12
10-K

Contact Information

Gaithersburg, MD
United States